ProShares Global Listed Private Equity ETF (PEX)
ETF analysis · CBOE · Financial Services · Asset Management
ProShares Global Listed Private Equity ETF (PEX) is an exchange-traded fund in the Financial Services sector. Latest price: $22.37. Market cap $10.29M. Sign in to Stocks360 for full DCF valuation, fundamentals, technicals, and AI-driven analysis.
Get full analysis → Short-Term Analysis →1-Year Price
Proprietary Signals
About ProShares Global Listed Private Equity ETF
PEX is the third launch in the Global Private Equity Segment and is a market-cap-selected and -weighted fund, thus offering plain vanilla exposure to investors. The underlying index tracks 30 qualifying listed private equity companies which were screened based on, among other things, greater relative trading volume. Generally, the fund will invest at least 80% of its total assets in component securities of the index, and will primarily invest in common stocks of domestic and foreign companies (including in large part BDCs for US-domiciled companies) of any size.
Peers
Recent News
- Rhelion Life Sciences' Wholly Owned Subsidiary Filament Health Ships PEX010 to the University of Calgary for Phase 2 Trial of Psilocybin-As…
- Rhelion Life Sciences' Wholly Owned Subsidiary Filament Health Expands Supply Agreement with the University of Chieti-Pescara for PEX010 in…
- Rhelion Life Sciences' Wholly Owned Subsidiary Filament Health Delivers PEX010 to Bruyere Health Research Institute's Phase 3 Trial of Micr…
- Rhelion Life Sciences' Wholly Owned Subsidiary Filament Health Signs Supply and Licensing Agreement with the Centre for Human Drug Research…
- Rhelion Life Sciences' Wholly Owned Subsidiary Filament Health Completes Shipment of PEX010 to Australia for University of Melbourne Trial…
Related
Browse more tickers: sitemap